“The femtosecond laser lets us manufacture each segment to exact specifications for each patient,” said Dr Cronin. “Combined with the Brisbane nomogram, this gives us a reproducible, tailored solution ...

Keratoconus is a rare, progressive ophthalmic disorder characterized by changes to the cornea that result in significant vision loss. Epioxa is an oxygen-enriched, UV-bioactivated topical treatment ...

Please provide your email address to receive an email when new articles are posted on . When a young patient presents with atypical refractive findings and an inability to see 20/20 in one eye, that ...

Keratoconus is a progressive, noninflammatory corneal disorder that causes corneal thinning and irregularity, resulting in impaired vision. It typically begins in adolescence and progresses slowly ...

Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — According to the National Keratoconus Foundation, Nov. 10 is World Keratoconus Day, which is ...

The commonly quoted number for the prevalence of keratoconus is 1:2000, which is pretty rare, although it varies by region of the world. Using mandatory health insurance data on 4.4 million patients ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

A pediatric subgroup from a pivotal phase 3 trial randomized 2:1 showed epithelium-on oxygen-enriched CXL improved Kmax at 6 ...